Radiopharm Theranostics Limited (RADX) Operating income 2023–2025
Radiopharm Theranostics Limited (RADX) annual operating income history from SEC filings — each fiscal year as reported.
-$38.2MFY2025 · since FY2023: -$34.5M → -$38.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$38.2M | +19.1% |
| FY2024 | -$47.2M | -36.9% |
| FY2023 | -$34.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RADX financial trends
RADX RevenueRADX Net incomeRADX Net marginRADX Gross profitRADX Gross marginRADX Operating marginRADX Operating cash flowRADX Free cash flowRADX Capital expendituresRADX Return on equityRADX Stock buybacksRADX Dividends paidRADX Total assetsRADX Total liabilitiesRADX Shareholders’ equityRADX overview →